Skip to main content

Advertisement

Log in

Impact of Highly Active Antiretroviral Therapy on the Natural History of Cervical Precancerous Lesions: A 17-Year Institutional Longitudinal Cohort Study

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

We performed an observational cohort study in order to assess the correlation between precancerous cervical lesions (cervical intraepithelial neoplasia [CIN]) and immunological state in human immunodeficiency virus (HIV)-positive women treated by highly active antiretroviral therapy (HAART). We analyzed 194 HIV-infected women referred to the Parma-Universitary Hospital for early detection of human papilloma virus–induced CINs. We analyzed cytology, colposcopy, and CIN degree according to HAART: group A untreated and group B treated. We compared the CD4+ count and viral load at the time of CIN onset and the time interval between diagnosis of HIV and the onset of CIN. Group A and group B showed homogeneous results for general features, CD4+ count, viral load, and Papanicolaou test features. Differences were not found in terms of histology and CD4+ value, viral load count, pharmacological treatment, years since the diagnosis of HIV, age, smoking, sexual promiscuity, previous intravenous narcotics abuse, prostitution, sexually transmitted diseases, ethnicity, and age at diagnosis. Histology and the clinical stage of HIV showed significant concordances between the high degree of cervical dysplasia and advanced stage of HIV disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. IARC: Monographs on the Evalutation of carcinogenic risks to Humans Volume 90. Human Papillomaviruses Lyon: AIRC Press; 2007. http://monographs.iarc.fr/ENG/Monographs/vol90/mono90.pdf. Accessed May 2013.

  2. Dal Maso L, Franceschi S, Lise M, et al. Screening of HIV-positive women in Emilia-Romagna (SHER) Study. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010;10:310.

    Article  Google Scholar 

  3. Dal Maso L, Polesel J, Serraino D, et al. Cancer and AIDS Registries Linkage (CARL) Study. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009; 100(5):840–847.

    Article  Google Scholar 

  4. Anastos K, Hoover DR, Burk RD, et al. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One. 2010;5(10):el3525.

    Article  Google Scholar 

  5. Gizzo S, Ancona E, Patrelli TS, et al. Fertility preservation in young women with cervical cancer: an oncologic dilemma or a new conception of fertility sparing surgery? Cancer Invest. 2013;31(3):189.

    Article  Google Scholar 

  6. Clifford GM, Franceschi S. Cancer risk in HIV-infected persons: influence of CD4(+) count. Future Oncol. 2009;5(5):669–678.

  7. Mogtomo ML, Malieugoue LC, Djiepgang C, Wankam M, Moune A, Ngane AN. Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer. 2009;4:9.

    Article  Google Scholar 

  8. Gonçalves MA, Soares EG, Donadi EA. The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity. Infect Agent Cancer. 2009;4:11.

    Article  Google Scholar 

  9. Società Italiana di Colposcopia e Patologia Cervico-Vaginale. Linee guida nella Gestione della Paziente con Pap Test Anormale; La colposcopia in Italia XII; 1, 2006. http://sigo.web-designer-roma.com/usr_files/linee-guida-sigo/LineeGuidaColposcopia06.pdf. Accessed May 2013.

  10. Società Italiana di Colposcopia e Patologia Cervico-Vaginale. Linee guida nella Gestione della Paziente con Pap Test Anormale; 1, 2002.

  11. The 1988 Bethesda system for reporting cervical/vaginal cytolo-gical diagnoses. national cancer institute workshop. JAMA. 1989;262(7):931–934.

    Article  Google Scholar 

  12. Broder S. From the national institutes of health. JAMA. 1992; 267(14):1892.

    Article  CAS  Google Scholar 

  13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–2119.

    Article  Google Scholar 

  14. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031–1037.

    Article  CAS  Google Scholar 

  15. De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008;17(6):545–554.

    Article  Google Scholar 

  16. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol. 2003;15(5):382–388.

    Article  Google Scholar 

  17. Stern PL, Brown M, Stacey SN, et al. Natural HPV immunity and vaccination strategies. J Clin Virol. 2000;19(1–2):57–66.

    Article  CAS  Google Scholar 

  18. Gage JR, Sandhu AK, Nihira M, et al. Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression. Obstet Gynecol. 2000;96(6):879–885.

    CAS  PubMed  Google Scholar 

  19. Massad LS, Evans CT, Weber KM, et al. Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immunodeficiency virus. Obstet Gynecol. 2010;116(4):941–947.

    Article  Google Scholar 

  20. Saccardi C, Gizzo S, Noventa M, et al. High-risk human papillomavirus DNA test: could it be useful in low-grade cervical lesion triage? five-year follow-up [published online June 6, 2013]. Reprod Sci. 2013.

  21. Soncini E, Zoncada A, Condemi V, Antoni AD, Bocchialini E, Soregotti P. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy. Acta Biomed. 2007;78(1):36–40.

    PubMed  Google Scholar 

  22. Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;51(3):274–282.

    Article  CAS  Google Scholar 

  23. Sirera G, Videla S, López-Blázquez R, et al. Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3. JAntimicrob Chemother. 2008;61(1):191–194.

    Article  CAS  Google Scholar 

  24. Heard I. Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS. 2009;4(1):68–73.

    Article  Google Scholar 

  25. Paramsothy P, Jamieson DJ, Heilig CM, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009;113(1):26–31.

    Article  Google Scholar 

  26. Massad LS, Evans CT, Wilson TE, et al. Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol. 2010;117(1):70–76.

    Article  Google Scholar 

  27. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, HIV/AIDS Cancer Match Study. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007; 99(12):962–972.

    Article  Google Scholar 

  28. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425–432.

    Article  Google Scholar 

  29. Tsai HT, Tsai YM, Yang SF, et al. Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm-a community-based case-control study. Gynecol Oncol. 2007; 105(1):181–188.

    Article  CAS  Google Scholar 

  30. Minkoff H, Zhong Y, Burk RD, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010;201(5):681–690.

    Article  Google Scholar 

  31. Gizzo S, Noventa M, Nardelli GB. Gardasil administration to hr-HPV-positive women and their partners. Trends Pharmacol Sci. 2013;34(9):479–480.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Salvatore Gizzo MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patrelli, T.S., Gizzo, S., Peri, F. et al. Impact of Highly Active Antiretroviral Therapy on the Natural History of Cervical Precancerous Lesions: A 17-Year Institutional Longitudinal Cohort Study. Reprod. Sci. 21, 837–845 (2014). https://doi.org/10.1177/1933719113512531

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719113512531

Keywords

Navigation